Results 21 to 30 of about 47,059 (243)

4131 Recruitment and Retention of Individuals with a Cocaine Use Disorder

Journal of Clinical and Translational Science, 2020
OBJECTIVES/GOALS: 1) illustrate the varied challenges individuals with a cocaine use disorder experience in daily life, 2) demonstrate techniques for empathizing and building rapport with potential subjects, and 3) identify recruitment obstacles and ...
Kate Brown, Bernadette Capili
doaj   +1 more source

Agonist Medications for the Treatment of Cocaine Use Disorder [PDF]

Neuropsychopharmacology, 2014
Cocaine addiction is a persistent and insidious public health problem (Pomara et al, 2012). Despite evidence for sustained prevalence, clinical harm, and demand for treatment, the Food and Drug Administration (FDA) has yet to approve any pharmacotherapy for its treatment.
S Stevens, Negus, Jack, Henningfield
openaire   +2 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Cocaine use disorder in females is associated with altered social decision-making: a study with the prisoner’s dilemma and the ultimatum game

BMC Psychiatry, 2019
Background Chronic cocaine use is associated with cognitive deficits, including poor performance on neuropsychological tasks of memory, executive functions, theory of mind and decision-making.
Thiago Wendt Viola, João Paulo Otolia Niederauer, Bruno Kluwe-Schiavon, Breno Sanvicente-Vieira, Rodrigo Grassi-Oliveira   +4 more
doaj   +1 more source

Calix[n]arene-based immunogens: A new non-proteic strategy for anti-cocaine vaccine

Journal of Advanced Research, 2022
Introduction: Cocaine use disorder is a significant public health issue without a current specific approved treatment. Among different approaches to this disorder, it is possible to highlight a promising immunologic strategy in which an immunogenic agent
Leonardo da Silva Neto, Angélica Faleiros da Silva Maia, Adriana Martins Godin, Paulo Sérgio de Almeida Augusto, Raissa Lima Gonçalves Pereira, Sordaini Maria Caligiorne, Rosemeire Brondi Alves, Simone Odília Antunes Fernandes, Valbert Nascimento Cardoso, Gisele Assis Castro Goulart, Felipe Terra Martins, Maila de Castro Lourenço das Neves, Frederico Duarte Garcia, Ângelo de Fátima   +13 more
doaj   +1 more source

The treatment of cocaine use disorder [PDF]

Science Advances, 2019
Current treatments for cocaine use disorder are often ineffective; new treatments are needed and are under development.
openaire   +2 more sources

Pharmacotherapy for Cocaine Use Disorders

, 2021
Cocaine is one of the most commonly used substances worldwide. It has a strong addictive potential, which often leads to excessive consumption causing pronounced physical and psychological harm to users. There is currently no approved or effective medication to treat cocaine use disorders.
Quednow, Boris B, Engeli, Etna J E, Herdener, Marcus   +2 more
openaire   +2 more sources

Cocaine and Marijuana Polysubstance Use and Cocaine Use Disorder: Investigating Mediated Effects through Patterns of Cocaine Use

Journal of Dual Diagnosis, 2020
Cocaine use is on the rise and it is comorbid with marijuana use. We examined the association between lifetime cocaine + marijuana polysubstance use (CM PSU) versus cocaine only and lifetime cocaine use disorder (CocUD) and examined the potential mediation by cocaine use patterns.
Yiyang Liu, JeeWon Cheong, Barry Setlow, Linda B. Cottler   +3 more
openaire   +3 more sources

Growing use of valproic acid in substance use disorders

European Psychiatry, 2022
Introduction Valproic acid is an antiepileptic drug used in different fields of Psychiatry. It is known mostly for its use in managing patients with bipolar affective disorder.
J. Romão, M. Gonçalves, M. Ribeiro, R. André, R. Saraiva, M. Abreu   +5 more
doaj   +1 more source

Bile acids modulate reinstatement of cocaine conditioned place preference and accumbal dopamine dynamics without compromising appetitive learning

Scientific Reports, 2023
Psychostimulants target the dopamine transporter (DAT) to elicit their psychomotor actions. Bile acids (BAs) can also bind to DAT and reduce behavioral responses to cocaine, suggesting a potential therapeutic application of BAs in psychostimulant use ...
Daniele Zanella, Nicholas K. Smith, J. Andrew Hardaway, Anna Marie Buchanan, Clarence H. Mullins, Aurelio Galli, Angela M. Carter   +6 more
doaj   +1 more source